19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

      Neuron
      Alzheimer Disease, psychology, Amyloid Precursor Protein Secretases, antagonists & inhibitors, Amyloid beta-Peptides, toxicity, Amyloid beta-Protein Precursor, genetics, physiology, Animals, Behavior, Animal, drug effects, Calcium Signaling, Cognition Disorders, Disease Progression, Electroencephalography, Entorhinal Cortex, pathology, Hippocampus, Humans, Immunohistochemistry, In Vitro Techniques, Maze Learning, Memory, Mice, Mice, Inbred C57BL, Mice, Transgenic, Nerve Net, Neurons, Phenotype, Plaque, Amyloid, Synapses

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The entorhinal cortex (EC) is one of the earliest affected, most vulnerable brain regions in Alzheimer's disease (AD), which is associated with amyloid-β (Aβ) accumulation in many brain areas. Selective overexpression of mutant amyloid precursor protein (APP) predominantly in layer II/III neurons of the EC caused cognitive and behavioral abnormalities characteristic of mouse models with widespread neuronal APP overexpression, including hyperactivity, disinhibition, and spatial learning and memory deficits. APP/Aβ overexpression in the EC elicited abnormalities in synaptic functions and activity-related molecules in the dentate gyrus and CA1 and epileptiform activity in parietal cortex. Soluble Aβ was observed in the dentate gyrus, and Aβ deposits in the hippocampus were localized to perforant pathway terminal fields. Thus, APP/Aβ expression in EC neurons causes transsynaptic deficits that could initiate the cortical-hippocampal network dysfunction in mouse models and human patients with AD. Copyright © 2010 Elsevier Inc. All rights reserved.

          Related collections

          Author and article information

          Comments

          Comment on this article